PATIENT/CLIENT DATA – CLINICAL DECISION-MAKING WORKSHEET
Student Name: | Week: | Dates of Care: |
Patient Initials
M.R
|
Sex F
|
Age 62
|
Room 616
|
Admitting Date 5/27/2022
|
Admitting Chief Complaint: What symptoms cause the patient to come to the hospital?
Right knee Arthrotomy Right knee patella revision
|
Attending physician/Treatment team:
Frisch, Nilesardo, Maya, long K Ham
|
Consults:
Hospitalist group, Md |
||||
Present Diagnosis: (Why patient is currently in the hospital)
· Left wrist pain · Right knee pain · Moderate episode of recurrent major depressive disorder (HCC) · Panic disorder with agoraphobia, mild agoraphobic avoidance, and mild panic attacks · Numbness and tingling in both hands · Mass of left wrist
|
ER Management: (if applicable)
Total knee replacement Right knee patella revision
|
||||
Allergies:
Niacin and Related
|
Code Status: Full code | Isolation: (type and reason) None
|
|||
Admission Height:
170.2 cm (5’7)
|
Admission Weight: 124.7 lg (275 lb)
|
Arm Band Location (colors & reasons)
|
|||
Communication needs: (verbal, nonverbal, barriers, languages)
No problem with communications. Can speak English and there were no language barriers.
|
|||||
Past Medical History: (pertinent & how managed)
· Anxiety · Arthritis (pt states osteoarthritis) · Asthma · Depression · Diabetes mellitus (HCC) · Diabetes mellitus, type 2 (HCC) · General weakness 2 to S/P. Lt. TKR (total knee replacement) using cement · GERD (gastroesophageal reflux disease) · Hypertension · Migrains · PONV (postoperative nausea and vomiting) · Right knee pain · Stroke (HCC) TIA x2 in 2011 and 2012 with LUE weakness
|
|||||
Significant Events during this hospitalization but not during this clinical time: (include the date, event and outcome)
A 62-year-old Hispanic female with a history as noted below presents for the elective procedure(s): The patient states did well after bilateral TKAs in 2014 but fell on R knee 2-3 months ago and has had patellar pain since that time, especially with weight-bearing, flexion, and turning Saw their care provider with concern for loosening of the prosthesis. No recent or other UTI/URI sx, chest pain, shortness of breath, orthopnea, PND, dizziness, syncope, palpitations, LE pain/swelling, fevers/chills, headaches, confusion, numbness/tingling/weakness, speech/swallowing/vision changes, back pain, abdominal pain, nausea, vomiting, diarrhea, constipation, melena/hematochezia, or COVID symptoms.
|
Tests/Treatments/Interventions impacting clinical day’s care (include current orders)
|
Assessments and interventions: (Include all pertinent data)
|
|
Vital signs: (2 sets per day)
Time 0942 1322 T 98.3 98.2 P 79 62 R 18 18 B/P 143/63 149/77 Time 1355 1425 T 98.2 98.5 P 94 88 R 18 18 B/P 154/72 170/69
|
GI:
Diet: Swallow precautions: Tube feedings: NG / G tube: Blood Glucose: (time & date) Last bowel movement: (time & date) Pertinent Labs/Test: Assessments/Interventions: (stool, bowel sounds, tenderness, distention, appetite, nausea, vomiting)
|
Respiratory:
02 modalities: 02 Saturation: Suction: Resp Rx’s: Trach: Chest Tubes: Pertinent Labs/Test: Assessments/Interventions: (Lung sounds, cough, sputum, SOB)
|
Neurosensory:
Neuro checks: Alert & Orientated: Follows commands: Speech Comprehensible: Pertinent Labs/Test: Assessments/Interventions: (LOC, pupils, Glascow Coma scale, dizziness, headaches, tremors, tingling, weakness, paralysis, numbness) |
Cardiovascular:
Telemetry: Pacemaker/IAD: DVT Prevention: Daily Weights: Pertinent Labs/Test: Assessments/Interventions: (peripheral pulses, heart sounds, murmurs, bruits, edema, chest pain, discomfort, palpitations)
|
Musculoskeletal:
Activity: Traction: Casts/Slings: Pertinent Labs/Test: Assessments/Interventions: (strength, ROM, pain, weakness, fractures, amputation, gait, transfers, CMS or 5 Ps
|
Renal:
Catheter (indwelling/external): CBI: Dialysis: A/V access: Pertinent Labs/Test: Assessments/Interventions: (location, bruit, thrill)(urine-quality, burning with urination, hematuria, incontinent, continent, I & O)
|
Skin:
Braden Score: Pertinent Labs/Test: Assessments/Interventions:(bruising, characteristics, turgor, surgical incision, finger & toe nails, wounds, drains, bed type)
|
Pain:
Pain score: Assessments/Interventions: (scale used, location, duration, intensity, character, exacerbation, relief, interventions)
|
Vascular Access: (IV site)
Assessments/Interventions: (include type of fluid & access, location, dressing, date inserted, tubing change, Site Appearance)
|
Gyn:
Gravida/Para: LMP: Last Pap: Breast exam: Pertinent Labs/Test Assessment/Interventions: (bleeding, discharge)
|
Post-operative /procedural:
Assessments/Interventions: (immediate post procedure care)
|
Safety:
Call light: Bed Rails: Bed alarms: Fall risk: Assistive Devices: Sitter use: Restraints (type, duration & reason): Assessment/Interventions (modifications to room, environment, Patient)
|
Advance Directives/Ethical considerations:
DPOA: Hospice:
|
Pertinent Data (Labs, X-rays, Etc.)
Results Normal Lab Values Significance to your patient WBC 10.0 RBC 4.20 HGB 12.4 HCT 36.4 MCV 86.7 MCH 29.5 MCHC 34.0 Platelets 12.9 RDW 198 MPV 7.3 PT N/A INR N/A APTT N/A Glucose 188 BUN 17 Creatinine 0.75 Sodium 138 Potassium 3.9 Cloride 103 Calcium 9.0 T Protein N/A Albumin N/A SGOT N/A SGPT N/A Alk Phos N/A Magnesium N/A Amylase N/A Lipase N/A CPK N/A LDH N/A Cholestrol N/A N/A CK N/A CK-MB N/A Troponin I N/A Myoglobin N/A LDI N/A Urinalysis N/A Color N/A Character N/A Spec. Grav. N/A pH N/A Protein N/A Glucose 165 (H) Acetone N/A Bilirubin N/A Blood N/A Nitr N/A Urobili N/A RBC N/A WBC N/A Epithelium N/A Urine Culture N/A Chest X-ray N/A MRI N/A CT Scan N/A Others test: N/A
|
|
Psycho/Social: Assessment/Interventions:(mental illness, social history, living arrangements, primary caregiver, substance abuse, maternal/infant bonding, family dynamics)
|
|
Cultural/Spiritual needs: Assessment/Interventions: (religious preference, adaptations & modifications, end of life decisions)
|
|
Growth & Development: (physical, psychosocial, cognitive, moral, spiritual using various theorist) What stage of development evident with patient:
|
Current overall plan of care: (A short statement that summarizes the anticipated plan of care)
|
Discharge plans and needs:
|
Teaching needs:(Disease process, medications, safety, style, barriers)
|
Pathophysiological Discussion: Discuss the current disease process at the cellular level (in your own words). Explain why this patient is encountering this particular health deficit. What is the relationship of this current health alteration to the patient’s other medical conditions? Describe the current disease process the patient is encountering etiology, epidemiology, pathophysical mechanism, manifestations and treatment (medical and surgical). Also note the complications that may occur with these treatments and the patient’s overall prognosis. Include appropriate references and use APA format.
Attach a research article pertaining to diagnosis of patient. Write a summary about the article.
List of nursing diagnoses (NANDA format). Place diagnoses in priority order and provide rationale for priority setting. May only list one nursing diagnosis that is a Risk For diagnosis.
Priority | Nursing Diagnosis | Related to | As Evidence By | Rationale (reason for priority) |
1 | ||||
2 | ||||
3 | ||||
4 | ||||
5 |
Medications |
Classification |
Dose |
Route |
Freq |
Purpose/Mechanism of Action |
Significant Side Effects / Adverse Reactions |
Nursing Implications |
Morphine PF
Injection
|
|
4mg | Intravenous | Every 4hrs PRN | Severe pain breakthrough pain |
|
|
Aluminum & Magnesium hydroxide (Maalox plus)
|
|
15ml | Oral | Every 6hrs PRN | Indigestion |
|
|
Docusate sodium (Colace) capsule
|
|
100 mg | Oral | 2 times daily | Constipation |
|
|
Enoxaparin
(Loveriox)
|
|
40mg | Injection Subcutaner | Every 12 hr |
|
|
|
Gabapentin
(Neurontin)
|
|
300 mg | Oral | Every 8 hrs |
|
|
|
Ibuprofen (Motrin)
|
|
600mg | Oral | Nightly PRN |
|
|
|
Ketorolac
(TORADOL) Injection
|
|
15mg | Intravenous | Every 6hrs |
|
|
|
Oxycodone
(Roxicodone)
|
|
10mg | Oral | Every 4hrs PRN | Immediate release, Severe pain |
|
|
Hydroxyzine (ATARAX)
|
|
25mg | Oral | Nightly PRN | Itching, sleep |
|
|
Nursing Diagnosis: Identify the top two nursing Diagnoses and expand
Assessment as evident by (AEB) or data collection relative to the nursing diagnosis (Appropriate for chosen diagnosis. Includes objective & Subjective historical data that support actual or risk for nursing diagnosis) |
Patient Goal(s)Statement of purpose for the patient to achieve |
Patient Outcome (Should be measurable, attainable, realistic and timed, all criteria should be present and specific to the patient Dx.)(Must have at least two short term outcomes and two long term outcomes)
|
Interventions/Implementations (Must have at least four nursing interventions for each outcome written that directly relate to the patient’s goal statement and help to reach the patient outcomes. They should be specific in action, frequency, and contain a rationale. |
Evaluation. (Was the outcome met, partially met or not met and why? And is the plan of care revised or continued and new evaluation date/time is set) |
Nursing Diagnosis: Identify the top two nursing Diagnoses and expand
Assessment as evident by (AEB) or data collection relative to the nursing diagnosis (Appropriate for chosen diagnosis. Includes objective & Subjective historical data that support actual or risk for nursing diagnosis) |
Patient Goal(s)Statement of purpose for the patient to achieve |
Patient Outcome (Should be measurable, attainable, realistic and timed, all criteria should be present and specific to the patient Dx.)(Must have at least two short term outcomes and two long term outcomes)
|
Interventions/Implementations (Must have at least four nursing interventions for each outcome written that directly relate to the patient’s goal statement and help to reach the patient outcomes. They should be specific in action, frequency, and contain a rationale. |
Evaluation. (Was the outcome met, partially met or not met and why? And is the plan of care revised or continued and new evaluation date/time is set) |
PAGE
1